Budesonide Inhalation Suspension
Product Images NDC 50090-7126

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Budesonide Inhalation (NDC 50090-7126). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (E986c849 75fc 4c78 B593 1bd0c878adf8 01)

Chemical structure diagrams of the active ingredient budesonide, showing its detailed molecular configuration and associated chemical groups.*

FDA Label Image

Image (E986c849 75fc 4c78 B593 1bd0c878adf8 02)

Line graph titled 'Nighttime Asthma Change from Baseline' showing mean change in nighttime asthma symptoms over weeks 0 to 12. The graph compares placebo with three budesonide inhalation doses: 0.25 mg, 0.5 mg, and 1.0 mg once daily. The vertical axis measures mean change from baseline, with improvements shown as negative changes. Statistical p-values for each dosage are provided at the bottom.*

FDA Label Image

Image (E986c849 75fc 4c78 B593 1bd0c878adf8 03)

A line graph titled "Nighttime Asthma Change from Baseline" showing mean change from baseline in nighttime asthma symptoms over weeks 0 to 12. Three lines represent placebo, 0.25 mg twice daily, and 0.5 mg twice daily treatments, displaying different symptom trajectories. P-values for 0.25 mg and 0.5 mg doses are 0.022 and 0.021 respectively.*

FDA Label Image

Image (E986c849 75fc 4c78 B593 1bd0c878adf8 04)

A line graph titled 'Nighttime Asthma Change from Baseline' showing mean change in nighttime asthma symptoms over 12 weeks for different dosages of budesonide inhalation suspension and placebo. The x-axis represents time in weeks, and the y-axis shows mean change from baseline. Lines for placebo, 0.25 mg once daily, 0.25 mg twice daily, 0.5 mg twice daily, and 1.0 mg once daily illustrate symptom changes. P-values for statistical comparisons at various dosages are also displayed below the graph.*

FDA Label Image

Image (E986c849 75fc 4c78 B593 1bd0c878adf8 05)

An instructional illustration showing a person holding a blister pack of unit-dose vials and removing a vial by twisting off its top. The image demonstrates proper handling of the vial for inhalation suspension medication.*

FDA Label Image

Image (E986c849 75fc 4c78 B593 1bd0c878adf8 06)

An instructional illustration showing a hand holding a small vial or ampule, with an arrow indicating a twisting motion at the base of the vial. This likely demonstrates how to open or prepare the budesonide inhalation suspension for use.*

FDA Label Image

Image (E986c849 75fc 4c78 B593 1bd0c878adf8 07)

An instructional illustration showing hands opening a small container by twisting its top. The image is likely related to the preparation or use of budesonide inhalation suspension for respiratory administration.*

FDA Label Image

Image (E986c849 75fc 4c78 B593 1bd0c878adf8 08)

An instructional line drawing showing a person holding a respiratory inhalation device while using a syringe to measure or withdraw liquid from the inhaler chamber. The illustration demonstrates the preparation or dosing process for budesonide inhalation suspension.*

FDA Label Image

Label Image (Lbl500907126)

Label for budesonide inhalation suspension 0.5 mg/2 mL by A-S Medication Solutions. The label indicates each single-dose ampule delivers 2 mL of a sterile suspension. It includes storage instructions to keep between 36 to 77 degrees Fahrenheit and protect from light. The package contains 30 single-dose ampules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.